Novartis in advanced talks to buy Cytokinetics

[cafead]

via Swiss drugmaker Novartis (NOVN.S) is in the lead to acquire Cytokinetics (CYTK.O) for a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

article source

 

[anonymous]

thanks pat doherty

 

[anonymous]

thanks pat doherty

 

[anonymous]

thanks pat doherty

 

[anonymous]

PATRICK DOHERTY, a/k/a Regional Business Manager at DOPI/SOPI/MOPEY in FLORIDA. Hired by You Know Who? STAN THE MAN!! There's an EEOC INVESTIGATION STILL!!
Whatever is next for the hematology division at SOBI now that it's for Sale? CHECK Seeking Alpha

1. But MORE IMPORTANTLY, PAT D GOT NAILED FOR INSIDER TRADING AT CYTOKINETICS. CHECK THE STOCK, DOWN MORE THAN 20 POINTS Wonder What HE DID AT SOBI!!!

DOVA THEN SOBI HIRES ARE THE BOTTOM OF SCUM. YOU MAY HAVE TO GO TO JAIL FOR THEM!!!! THEY ARE NOT WORTH IT. IF YOU WORK THERE, GET OUT!!! NO GOOD NEWS IS COMING.

 

[anonymous]

PATRICK DOHERTY, a/k/a Regional Business Manager at DOPI/SOPI/MOPEY in FLORIDA. Hired by You Know Who? STAN THE MAN!! There's an EEOC INVESTIGATION STILL!!
Whatever is next for the hematology division at SOBI now that it's for Sale? CHECK Seeking Alpha

1. But MORE IMPORTANTLY, PAT D GOT NAILED FOR INSIDER TRADING AT CYTOKINETICS. CHECK THE STOCK, DOWN MORE THAN 20 POINTS Wonder What HE DID AT SOBI!!!

DOVA THEN SOBI HIRES ARE THE BOTTOM OF SCUM. YOU MAY HAVE TO GO TO JAIL FOR THEM!!!! THEY ARE NOT WORTH IT. IF YOU WORK THERE, GET OUT!!! NO GOOD NEWS IS COMING.